VMP 41791611000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Mebendazole 100mg/5ml oral suspension
BNF code 0505010D0AAAAAA
Virtual Therapeutic Moiety Mebendazole
Date identifier became valid 12 May 2023
Previous product identifier 324962006
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure spoonful
Virtual Product Ingredient
Ingredient Mebendazole
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Oral suspension
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Ovex 100mg/5ml oral suspension (Johnson & Johnson Ltd)
Vermox 100mg/5ml oral suspension (Janssen-Cilag Ltd)
Vermox 100mg/5ml oral suspension (Sigma Pharmaceuticals Plc)
Vermox 100mg/5ml oral suspension (Stephar (U.K.) Ltd)
Virtual Medicinal Product Packs
Mebendazole 100mg/5ml oral suspension 30 ml

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback